Mariachiara Arisi

Mariachiara Arisi

Auto-generated profile, based on publicly available information

Mariachiara Arisi

Department of Dermatology University of Brescia Brescia Italy

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Clinical, Cosmetic and Investigational Dermatology
Verified
Journal Article
Open access
PDF file
MAMariachiara Arisi
Mariachiara Arisi
EPEdoardo Guasco Pisani
Edoardo Guasco Pisani
PCPiergiacomo Calzavara-Pinton
Piergiacomo Calzavara-Pinton
CZCristina Zane
Cristina Zane
Actinic keratoses (AKs) are pre-malignant epithelial lesions induced by chronic cumulative UV exposure. Several guidelines concerning AKs treatment have been published in the past years. Among destructive procedures, cryotherapy is today considered a standard first-line approach in case of single lesions. The aim of the present review article is to analyse the treatment technique, its efficacy and safety.

3 June 2021 in American Journal of Surgical Pathology
Verified
Journal Article
Open access
LLLuisa LORENZI
Luisa LORENZI
SLSilvia Lonardi
Silvia Lonardi
DVDonatella Vairo
Donatella Vairo
ABAndrea Bernardelli
Andrea Bernardelli
MTMichela ThS Tomaselli
Michela ThS Tomaselli
FFFabio Facchetti
Fabio Facchetti
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive neoplasm derived from plasmacytoid dendritic cells (pDCs). In this study, we investigated by immunohistochemical analysis the expression of E-cadherin (EC) on pDCs in reactive lymph nodes and tonsils, bone marrow, and in BPDCN. We compared the expression of EC in BPDCN to that in leukemia cutis (LC) and cutaneous lupus erythematosus (CLE), the latter typically featuring pDC activation. In BPDCN, we also assessed the immunomodulatory activity of malignant pDCs through the expression of several type I interferon (IFN-I) signaling effectors and downstream targets, PD-L1/CD274, and determined the extent of tumor infiltration by CD8-expressing T cells. In reactive lymph nodes and tonsils, pDCs expressed EC, whereas no reactivity was observed in bone marrow pDCs. BPDCN showed EC expression in the malignant pDCs in the vast majority of cutaneous (31/33 cases, 94%), nodal, and spleen localizations (3/3 cases, 100%), whereas it was more variable in the bone marrow (5/13, 38,5%), where tumor cells expressed EC similarly to the skin counterpart in 4 cases and differently in other 4. Notably, EC was undetectable in LC (n=30) and in juxta-epidermal pDCs in CLE (n=31). Contrary to CLE showing robust expression of IFN-I-induced proteins MX1 and ISG5 in 20/23 cases (87%), and STAT1 phosphorylation, BPDCN biopsies showed inconsistent levels of these proteins in most cases (85%). Expression of IFN-I-induced genes, IFI27, IFIT1, ISG15, RSAD2, and SIGLEC1, was also significantly (P<0.05) lower in BPDCN as compared with CLE. In BPDCN, a significantly blunted IFN-I response correlated with a poor CD8+T-cell infiltration and the lack of PD-L1/CD274 expression by the tumor cells. This study identifies EC as a novel pDC marker of diagnostic relevance in BPDCN. The results propose a scenario whereby malignant pDCs through EC-driven signaling promote the blunting of IFN-I signaling and, thereby, the establishment of a poorly immunogenic tumor microenvironment.

18 March 2021 in Dermatology and Therapy
Verified
Journal Article
Open access
PDF file
MAMariachiara Arisi
Mariachiara Arisi
SSSimone Soglia
Simone Soglia
EPEdoardo Guasco Pisani
Edoardo Guasco Pisani
AVAnna Venturuzzo
Anna Venturuzzo
AGAlessandra Gelmetti
Alessandra Gelmetti
PCPiergiacomo Calzavara-Pinton
Piergiacomo Calzavara-Pinton
Introduction Cold atmospheric plasma (CAP) has been clinically demonstrated to be an effective treatment for actinic keratosis (AK) in a number of case series. In this study, we evaluated the efficacy of CAP in the treatment of multiple AKs and assessed morphological changes induced on the skin field of cancerization both clinically and by high-frequency ultrasound (HFUS). Methods Patients with multiple grade I–II AKs of the scalp and/or face who were resistant or intolerant to conventional field-directed treatments were enrolled. CAP treatments were performed using a microwave-driven argon plasma jet. At baseline and 3 months after the last CAP session, performance indexes were determined using three-dimensional digital pictures and HFUS investigations were performed on a representative Olsen grade II AK and a small spot of clinically unaffected skin within the test area. Results Twelve patients were enrolled in the study. All clinical variables showed a statistically significant reduction after CAP. HFUS evaluation revealed that the total, epidermal and dermal thicknesses of the target AKs had not changed with treatment. CAP therapy significantly increased dermal density in both the target AK and the surrounding photodamaged skin and signficantly decreased the thickness of the subepidermal low-echogenic band in the perilesional skin, which is an ultrasound sign of photodamage. Conclusions Cold atmospheric plasma was found to be an effective treatment for patients with multiple AKs. CAP was not followed by skin atrophy. HFUS examiniation showed the CAP improved features of chronic photodamage of the dermis of the skin underlying and surrounding the AK spots.

17 April 2023 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
GLGaetano Licata
Gaetano Licata
VTVittorio Tancredi
Vittorio Tancredi
EPElena Pezzolo
Elena Pezzolo
GPGinevra Pertusi
Ginevra Pertusi
ETErsilia Tolino
Ersilia Tolino
AGAlessio Gambardella
Alessio Gambardella

4 July 2018 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
MAM. Arisi
M. Arisi
LLLuisa LORENZI
Luisa LORENZI
PIP. Incardona
P. Incardona
MFM. Fusano
M. Fusano
AZA. Zanca
A. Zanca
MVMARINA VENTURINI
MARINA VENTURINI

2 December 2019 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
MAM. Arisi
M. Arisi
CZC. Zane
C. Zane
MPM. Polonioli
M. Polonioli
CTC. Tomasi
C. Tomasi
EME. Moggio
E. Moggio
PCP.G. Calzavara‐Pinton
P.G. Calzavara‐Pinton